{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:16:37Z","timestamp":1760145397794,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.micpath.2019.03.032","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T14:52:41Z","timestamp":1553611961000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-889X","authenticated-orcid":false,"given":"Hoda","family":"El Aggan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahla","family":"Farahat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevine","family":"El Deeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Zeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assem","family":"El-Shendidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.micpath.2019.03.032_bib1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4254\/wjh.v9.i33.1239","article-title":"Global elimination of hepatitis C virus infection: progresses and the remaining challenges","volume":"9","author":"Taherkhani","year":"2017","journal-title":"World J. Hepatol."},{"year":"2009","series-title":"Egypt Demographic and Health Survey 2008, Cairo, Egypt","author":"El-Zanaty","key":"10.1016\/j.micpath.2019.03.032_bib2"},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.13186","article-title":"The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment","volume":"37","author":"Kandeel","year":"2017","journal-title":"Liver Int."},{"issue":"1 Suppl","key":"10.1016\/j.micpath.2019.03.032_bib4","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J. Hepatol."},{"issue":"32","key":"10.1016\/j.micpath.2019.03.032_bib5","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.micpath.2019.03.032_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2016.06.009","article-title":"Innate immunity against hepatitis C virus","volume":"42","author":"Xu","year":"2016","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib7","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jmb.2013.10.032","article-title":"Activation and evasion of antiviral innate immunity by hepatitis C virus","volume":"426","author":"Horner","year":"2014","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.micpath.2019.03.032_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.micpath.2019.03.032_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.str.2011.02.004","article-title":"The structural biology of Toll-like receptors","volume":"19","author":"Botos","year":"2011","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jhep.2009.03.012","article-title":"Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7","volume":"51","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"issue":"5663","key":"10.1016\/j.micpath.2019.03.032_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.micpath.2019.03.032_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2019.03.032_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cytogfr.2006.07.001","article-title":"Interferon: the pathways of discovery. Molecular and cellular aspects","volume":"17","author":"Billiau","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.micpath.2019.03.032_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2017.00119","article-title":"Interferon lambda: modulating immunity in infectious diseases","volume":"8","author":"Syedbasha","year":"2017","journal-title":"Front. Immunol."},{"issue":"31","key":"10.1016\/j.micpath.2019.03.032_bib15","doi-asserted-by":"crossref","first-page":"20869","DOI":"10.1074\/jbc.M109.002923","article-title":"Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family","volume":"284","author":"Gad","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.micpath.2019.03.032_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.coi.2011.07.007","article-title":"IFN-lambdas (IFNLs)","volume":"23","author":"Kotenko","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2019.03.032_bib17","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1074\/jbc.M608618200","article-title":"Viral infections activate types I and III interferon genes through a common mechanism","volume":"282","author":"Onoguchi","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2019.03.032_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2005.04.003","article-title":"Biological activity of interleukins-28 and -29: comparison with type I interferons","volume":"31","author":"Meager","year":"2005","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.micpath.2019.03.032_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thoraxjnl-2014-205465","article-title":"Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia","volume":"70","author":"Hatchwell","year":"2015","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.micpath.2019.03.032_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000369342","article-title":"Unc93b1-dependent endosomal Toll-like receptor signaling regulates inflammation and mortality during Coxsackievirus B3 infection","volume":"7","author":"Lafferty","year":"2015","journal-title":"J. Innate Immun."},{"issue":"3","key":"10.1016\/j.micpath.2019.03.032_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.burns.2012.07.019","article-title":"The effect of TLR4\/7 on the TGF-\u03b2-induced Smad signal transduction pathway in human keloid","volume":"39","author":"Chen","year":"2013","journal-title":"Burns"},{"issue":"10","key":"10.1016\/j.micpath.2019.03.032_bib23","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1440-1746.2006.04783.x","article-title":"Expression of Toll-like receptors in chronic hepatitis C virus infection","volume":"22","author":"Sato","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.micpath.2019.03.032_bib24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3748\/wjg.v12.i8.1198","article-title":"Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection","volume":"12","author":"Dolganiuc","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.micpath.2019.03.032_bib25","article-title":"Relative expression of Toll-like receptor 2 and 7 mRNA in peripheral blood of patients with hepatitis","volume":"15","author":"Dehghan-Manshadi","year":"2015","journal-title":"C. Hepat. Mon."},{"issue":"7","key":"10.1016\/j.micpath.2019.03.032_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2362.2010.02295.x","article-title":"NF-kappa B, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease","volume":"40","author":"St\u00e4rkel","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib27","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1073\/pnas.0510801103","article-title":"Activation of anti-hepatitis C virus responses via Toll-like receptor 7","volume":"103","author":"Lee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.micpath.2019.03.032_bib28","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00705-014-2167-3","article-title":"Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758","volume":"159","author":"Yang","year":"2014","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.micpath.2019.03.032_bib29","article-title":"Distinct Toll-like receptor 3 and 7 expression in peripheral blood mononuclear cells from patients with chronic hepatitis C infection","volume":"14","author":"Motavaf","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.micpath.2019.03.032_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejmhg.2014.07.003","article-title":"Study of Toll-like receptor 7 expression and interferon \u03b1 in Egyptian patients with chronic hepatitis C infection and hepatocellular carcinoma, Egypt","volume":"15","author":"Abdel-Raouf","year":"2014","journal-title":"J. Med. Hum. Genet."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib31","first-page":"13","article-title":"Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha, Egypt","volume":"20","author":"Mohammed","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.23256","article-title":"Impaired expression and function of Toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells","volume":"51","author":"Chang","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.micpath.2019.03.032_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2893.2010.01331.x","article-title":"Decreased IFN-\u03b3 production correlates with diminished production of cytokines by dendritic cells in patients infected with hepatitis C virus and receiving therapy","volume":"18","author":"Hammond","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib34","first-page":"233","article-title":"In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C","volume":"27","author":"Tarantino","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"10","key":"10.1016\/j.micpath.2019.03.032_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044915","article-title":"Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells","volume":"7","author":"Dolganiuc","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.micpath.2019.03.032_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015200","article-title":"Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus","volume":"5","author":"Diegelmann","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.micpath.2019.03.032_bib37","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1074\/jbc.M113.536102","article-title":"Transcriptional regulation of IFNL genes in hepatitis C virus-infected hepatocytes via IRF-3\u00b7IRF-7\u00b7NF-\u03baB complex","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib38","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/hep.25897","article-title":"IL-29 is the dominant Type III interferon produced by hepatocytes during acute hepatitis C virus infection","volume":"56","author":"Park","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.micpath.2019.03.032_bib39","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.27227","article-title":"HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection","volume":"60","author":"Israelow","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.micpath.2019.03.032_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhep.2011.07.017","article-title":"Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients","volume":"56","author":"Jouan","year":"2012","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.micpath.2019.03.032_bib42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.21159","article-title":"Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)\/ribavirin therapy","volume":"43","author":"Jensen","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000363386","article-title":"Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients","volume":"57","author":"Petruzziello","year":"2014","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1665-2681(19)31676-X","article-title":"Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico","volume":"9","author":"Jimenez-Mendez","year":"2010","journal-title":"Ann. Hepatol."},{"issue":"2","key":"10.1016\/j.micpath.2019.03.032_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.micpath.2019.03.032_bib46","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for the grading and staging of histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.micpath.2019.03.032_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.humpath.2012.06.015","article-title":"Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma","volume":"44","author":"Lin","year":"2013","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/labinvest.3700490","article-title":"Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia","volume":"87","author":"Huang","year":"2007","journal-title":"Lab. Invest."},{"issue":"7\u20138","key":"10.1016\/j.micpath.2019.03.032_bib49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.18632\/oncoscience.317","article-title":"ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors","volume":"3","author":"Cai","year":"2016","journal-title":"Oncoscience"},{"issue":"2","key":"10.1016\/j.micpath.2019.03.032_bib50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.imbio.2014.08.007","article-title":"Monocytes and infection: modulator, messenger and effector","volume":"220","author":"Xiong","year":"2015","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.micpath.2019.03.032_bib51","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4049\/jimmunol.1600797","article-title":"Circulating and exosome-packed hepatitis C singlr-stranded RNA induce monocyte differentiation via TLR7\/TLR8 to polarized macrophages and fibrocytes","volume":"198","author":"Saha","year":"2017","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2019.03.032_bib52","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bbrc.2005.08.209","article-title":"Viruses selectively upregulate Toll-like receptors in the central nervous system","volume":"336","author":"Mckimmie","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.micpath.2019.03.032_bib53","article-title":"Hepatitis C virus pathogen-associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells, PLoS","volume":"9","author":"Stone","year":"2013","journal-title":"Pathog."},{"key":"10.1016\/j.micpath.2019.03.032_bib54","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3389\/fimmu.2017.01661","article-title":"Interferon (IFN)-\u03bb takes the Helm: immunomodulatory roles of type III IFNs","volume":"8","author":"Zanoni","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2019.03.032_bib55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.gene.6364382","article-title":"Human interferon lambda-1 (IFNL1\/IL-29) modulates the Th1\/Th2 response","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib56","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.4049\/jimmunol.1202689","article-title":"Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice","volume":"190","author":"Sun","year":"2013","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039161","article-title":"UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection","volume":"7","author":"Crane","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib58","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-\u03bb2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.gastro.2011.04.006","article-title":"Interferon-\u03bb mediates oral tolerance and inhibits antigen-specific T-helper 2 cell-mediated inflammation in mouse intestine","volume":"141","author":"He","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib60","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.20140995","article-title":"IFNL resolves inflammation via suppression of neutrophil infiltration and IL-1\u03b2 production","volume":"212","author":"Blazek","year":"2015","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.micpath.2019.03.032_bib61","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/eji.201445211","article-title":"Ligation of TLR7 on CD19 (+) CD1d (hi) B cells suppresses allergic lung inflammation via regulatory T cells","volume":"45","author":"Khan","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2019.03.032_bib62","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1189\/jlb.0307157","article-title":"IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages","volume":"82","author":"Pirhonen","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.micpath.2019.03.032_bib63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2007.03.021","article-title":"A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection","volume":"47","author":"Schott","year":"2007","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.micpath.2019.03.032_bib64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jvh.12099","article-title":"Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment","volume":"20","author":"Ackefors","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.micpath.2019.03.032_bib65","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ajt.12165","article-title":"Toll-like receptor 3 and 7\/8 function is impaired in hepatitis C rapid fibrosis progression post-liver transplantation","volume":"13","author":"Howell","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/hep.26981","article-title":"Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis","volume":"60","author":"Roh","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.micpath.2019.03.032_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/BJ20112058","article-title":"Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype","volume":"447","author":"Chou","year":"2012","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.micpath.2019.03.032_bib68","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00535-014-1023-2","article-title":"Association of serum IFNL3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection","volume":"50","author":"Aoki","year":"2015","journal-title":"J. Gastroenterol."},{"issue":"17","key":"10.1016\/j.micpath.2019.03.032_bib69","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1128\/JVI.00649-07","article-title":"Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines","volume":"81","author":"Abe","year":"2007","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.micpath.2019.03.032_bib70","article-title":"HCV-Induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1, PloS","volume":"9","author":"Chen","year":"2013","journal-title":"Pathog."},{"issue":"3","key":"10.1016\/j.micpath.2019.03.032_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009602","article-title":"Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users, PLoS","volume":"5","author":"Ye","year":"2010","journal-title":"One"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018317042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018317042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:20:54Z","timestamp":1760109654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018317042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":71,"alternative-id":["S0882401018317042"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2019.03.032","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2019.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}